Suscribirse

European study on Pneumocystis jirovecii short tandem repeats genotyping reveals wide population diversity with geographic specificities - 16/06/16

Doi : 10.1016/j.mycmed.2016.04.017 
A. Alanio 1, , M. Gits-Muselli 1, E. Calderon 2, D. Di Cave 3, D. Dupont 4, A. Hamprecht 5, P. Hauser 6, J. Helweg-Larsen 7, M. Kicia 8, K. Lagrou 9, 10, M. Lengerova 11, O. Matos 12, W. Melchers 13
1 Hôpital Saint-Louis, Paris, France 
2 Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain 
3 Department of experimental medicine and surgery University of rome “tor vergata”, Roma, Italy 
4 Hospices Civils de Lyon, institut de parasitologie mycologie médicale, hôpital de la Croix-Rousse, Lyon, France 
5 Institut für medizinische Mikrobiologie, Immunologie und Hygiene Universitätsklinikum, Köln, Germany 
6 Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland 
7 Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark 
8 Department of Biology and Medical Parasitology, Wroclaw Medical University, Wroclaw, Poland 
9 Department of Microbiology and Immunology, Catholic University Leuven, Leuven, Belgium 
10 National Reference Center for Mycosis, Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium 
11 University Hospital Brno, Brno, Czech Republic 
12 Medical Parasitology Unit, Group of Opportunistic Protozoa/HIV and Other Protozoa, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisbon, Portugal 
13 Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands 

Corresponding author.

Resumen

Introduction

Pneumocystis jirovecii is a human specific uncultivable ascomycetous fungus, for which the reservoir is immunocompetent human individuals. Immunocompromised patients are at risk of developing pneumocystis pneumonia (PCP) when exposed to P.jirovecii through their immediate environment. A recently described short tandem repeat (STR) typing strategy was applied to a population of patients from Paris and found a high diversity of genotypes (Gts) between the patients, but identical Gts reflecting putative interhuman nosocomial transmission [1]. In contrast, another genotyping study using a different STR set described a limited global population of P.jirovecii testing isolates recovered from Africa (n=13), USA (n=49) and Europe (n=29) [2]. Our objective is to determine the distribution of P.jirovecii STR genotypes across European hospitals.

Methods

We investigated a collection of 355 P.jirovecii microscopy or PCR positive respiratory samples recovered from 355 PCP patients in 12 European countries [France (n=5), Belgium, The Netherlands, Denmark, Germany, UK, Poland, Czech republic, Switzerland, Italy, Spain, and Portugal]. STR typing was performed as previously described [1]. Amplification failure occurred in 32% of the samples, likely a result of insufficient P.jirovecii DNA. Therefore, 242 samples (median: 17 per center (8–24)) were further analyzed.

Results

Mixtures of STR markers >1 allele for ≥ 1 locus) were detected in 66.7% [range: 36.4%–90.9%] of the samples, with a trend towards a lower proportion of mixtures in France-centre 2 and Belgium.

The distribution of alleles in all six markers was significantly different according to the countries in STRPj_138 (p=0.0002), STRPj_278 (p=0.0085), and STRPj_279 (p=0.0069).

Genotyping was analyzed only in samples harboring one allele/locus (n=87) or several alleles for one locus only (n=56). This provided 200 analyzable combinations corresponding to 143 Gts. Of them, 123 were found only in one country, 16 in two, 2 in three and one in 4 and 5 countries. Nine Gts were found more than once in a given country. Gt123 was significantly associated with France (14/15, p=0.0007) and Gt132 with Belgium (5/5, p<0.0001). In details, Center 2 in France and Belgium were associated with a high proportion of one genotype (42.8% of Gt123 and 100% of Gt132, respectively), suggesting enrichment in one geographical area or increased interhuman transmission in the corresponding hospitals.

Conclusion

Our study of 16 European centers showed a wide population diversity across Europe. However, focusing on centers, our results evidenced clusters of patients harboring a given genotype suggesting nosocomial interhuman transmission and potential outbreak situations.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2016  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 26 - N° 2

P. e5-e6 - juin 2016 Regresar al número
Artículo precedente Artículo precedente
  • Évaluation d’une approche métagénomique ciblée pour la caractérisation de la composition microbiologique de poussière de logement
  • S. Rocchi, B. Valot, A. Naegele, G. Reboux, L. Millon
| Artículo siguiente Artículo siguiente
  • Impact des antifongiques sur la résistance des principales espèces de Candida en réanimation–Evolution et tendances sur 10 ans
  • S. Bailly, D. Maubon, P. Fournier, H. Pelloux, C. Schwebel, C. Chapuis, L. Foroni, M. Cornet, J. Timsit

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.